Efficient in vitro labeling of human prostate cancer cells with superparamagnetic iron oxide nanoparticles

Cancer Biotherapy and Radiopharmaceuticals

Volumn 26, Issue 4, 2011, Pages 461-467

  Jiang, Jun ^a   Chen, Yaqing ^a   Zhu, Yunkai ^a   Yao, Xiaohong ^a   Qi, Jun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

molecular imaging; nanoparticles; poly l lysine (PLL); prostate cancer; superparamagnetic

Indexed keywords

FERUCARBOTRAN; POLYLYSINE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL LABELING; CELL VIABILITY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG EFFICACY; DRUG TUMOR LEVEL; FEASIBILITY STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER;

CELL LINE, TUMOR; CELL SURVIVAL; FERRIC COMPOUNDS; FERROCYANIDES; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; PROSTATIC NEOPLASMS; STAINING AND LABELING; TRANSFECTION;

EID: 80051745451     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2010.0934     Document Type: Article

References (21)

1. Thorek DL, Chen AK, Czupryna J, et al. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 2006;34:23.
2. Weissleder R, Mahmood U. Molecular imaging. Radiology 2001;219:316.
3. Bulte JW. In vivo MRI cell tracking: clinical studies. AJR Am J Roentgenol 2009;193:314.
4. Arbab AS, Liu W, Frank JA. Cellular magnetic resonance imaging: Current status and future prospects. Expert Rev Med Devices 2006;3:427.
5. Bulte JW, Laughlin PG, Jordan EK, et al. Tagging of T cells with superparamagnetic iron oxide: Uptake kinetics and relaxometry. Acad Radiol 1996;3(suppl 2):S301.
6. Lewin M, Carlesso N, Tung CH, et al. Tat peptidederivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000;18:410.
7. Ahrens ET, Feili-Hariri M, Xu H, et al. Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging. Magn Reson Med 2003;49:1006.
8. Raynal I, Prigent P, Peyramaure S, et al. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: Mechanisms and comparison of ferumoxides and ferumoxtran-Invest. Radiol 2004;39:56.
9. Park BH, Jung JC, Lee GH, et al. Comparison of labeling efficiency of different magnetic nanoparticles into stem cell. Colloids Surfaces A: Physicochem Eng Aspects 2008;313- 314:145.
10. Kalish H, Arbab AS, Miller BR, et al. Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: Relationship between relaxivities, electrostatic forces, and chemical composition. Magn Reson Med 2003;50:275.
11. Arbab AS, Bashaw LA, Miller BR, et al. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: Methods and techniques. Transplantation 2003;76:1123.
12. Neri M, Maderna C, Cavazzin C, et al. Efficient in vitro labeling of human neural precursor cells with superparamagnetic iron oxide particles: Relevance for in vivo cell tracking. Stem Cells 2008;26:505.
13. Song M, Moon WK, Kim Y, et al. Labeling efficacy of superparamagnetic iron oxide nanoparticles to human neural stem cells: Comparison of ferumoxides, monocrystalline iron oxide, cross-linked iron oxide (CLIO)-NH2 and tat-CLIO. Korean J Radiol 2007;8:365.
14. Hoehn M, Kustermann E, Blunk J, et al. Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A 2002;99:16267.
15. Frank JA, Miller BR, Arbab AS, et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003;228:480.
16. Arbab AS, Yocum GT, Wilson LB, et al. Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol Imaging 2004;3:24.
17. Matuszewski L, Persigehl T, Wall A, et al. Cell tagging with clinically approved iron oxides: Feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology 2005;235:155.
18. Emerit J, Beaumont C, Trivin F. Iron metabolism, free radicals, and oxidative injury. Biomed Pharmacother 2001;55:333.
19. Knobel Y, Glei M, Osswald K, et al. Ferric iron increases ROS formation, modulates cell growth and enhances genotoxic damage by 4-hydroxynonenal in human colon tumor cells. Toxicol In Vitro 2006;20:793.
20. Tanimoto A, Wakabayashi G, Shinmoto H, et al. Superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions: A comparison with CT during arterioportography plus CT during hepatic arteriography. J Gastroenterol 2005;40:371.
21. Pawelczyk E, Arbab AS, Chaudhry A, et al. In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages from labeled stem cells: Implications for cellular therapy. Stem Cells 2008; 26:1366.